Lantern Pharma Inc. (LTRN): Price and Financial Metrics
LTRN Price/Volume Stats
Current price | $5.07 | 52-week high | $11.99 |
Prev. close | $5.30 | 52-week low | $2.79 |
Day low | $5.00 | Volume | 64,200 |
Day high | $5.59 | Avg. volume | 141,752 |
50-day MA | $3.86 | Dividend yield | N/A |
200-day MA | $4.28 | Market Cap | 54.68M |
LTRN Stock Price Chart Interactive Chart >
Lantern Pharma Inc. (LTRN) Company Bio
Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-11, LP-300, and LP-184. The company was founded by Arun K. Asaithambi, Gregory T. Tobin, and Peter L. Nara on November 7, 2013 and is headquartered in Dallas, TX.
LTRN Price Returns
1-mo | N/A |
3-mo | 32.03% |
6-mo | 31.35% |
1-year | 19.86% |
3-year | -28.19% |
5-year | N/A |
YTD | 58.93% |
2024 | -25.47% |
2023 | -29.14% |
2022 | -24.31% |
2021 | -58.55% |
2020 | N/A |
Loading social stream, please wait...